Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Still disease]

S Vignes1, B Wechsler, J C Piette

  • 1Service de médecine interne, hôpital Saint-Louis, Paris, France.

La Revue De Medecine Interne
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Adult onset Still's disease is a rare systemic condition that is challenging to diagnose. While steroids are effective for symptom management, new treatments and specific diagnostic markers like ferritin are needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of virtual fencing in a mountain environment and its impact on heifer behaviour and welfare.

Animal : an international journal of animal bioscience·2025
Same author

Risk factors for tail lesions in undocked fattening pigs reared on Swiss farms.

Schweizer Archiv fur Tierheilkunde·2020
Same author

Body size in relation to cubicle dimensions affects lying behavior and joint lesions in dairy cows.

Journal of dairy science·2020
Same author

Can anticoagulation therapy in cerebral venous thrombosis associated with Behçet's disease be stopped without relapse?

Revue neurologique·2018
Same author

Effect of rubber mats and perforation in the lying area on claw and limb lesions of fattening pigs.

Animal : an international journal of animal bioscience·2018
Same author

Moderate lameness leads to marked behavioral changes in dairy cows.

Journal of dairy science·2018
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Area of Science:

  • Rheumatology
  • Internal Medicine

Context:

  • Adult onset Still's disease (AOSD) is a rare systemic autoinflammatory disorder.
  • Diagnosis relies on exclusion and Yamaguchi criteria, often delayed.
  • Clinical and prognostic factors are diverse, impacting joint and organ health.

Purpose:

  • To highlight diagnostic challenges and prognostic factors in Adult onset Still's disease.
  • To emphasize the importance of ferritin as a potential diagnostic marker.
  • To underscore the need for improved treatment strategies and specific biomarkers.

Summary:

  • Adult onset Still's disease presents with varied symptoms and is difficult to diagnose, often requiring exclusion of other conditions.
  • Joint involvement significantly impacts functional prognosis, while organ failure, infections, or amyloidosis affect vital prognosis.

Related Experiment Videos

  • Elevated ferritin levels are a crucial but currently unutilized biological marker for AOSD.
  • Impact:

    • This research emphasizes the need for updated diagnostic criteria for AOSD incorporating ferritin.
    • It calls for the development of novel therapeutic approaches beyond current steroid-based treatments.
    • Improved diagnostic accuracy and targeted therapies can enhance patient outcomes and quality of life.